SAN FRANCISCO--(BUSINESS WIRE)--
Invitae Corporation (NYSE:NVTA), a genetic information company, today
announced it will be presenting seven posters at the 2015 American
College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting in
Salt Lake City.
The titles and schedule of the poster presentations are as follows:
Poster Session 1: Thursday, March 26, 10:30 a.m. – 12:00 p.m. MT
-
Poster #105: Next-Generation Panel vs. Traditional BRCA1/2 Testing:
Challenging Variants, Classification Under the Draft ACMG ISV
Guidelines and Potential Actionability of Findings
-
Poster #139: Expanding the Clinical Spectrum of Mosaic Mutations in
TP53 Identified by Next-Generation Sequencing: A Retrospective Analysis
-
Poster #247: Early Onset Charcot-Marie-Tooth Disease with
Diaphragmatic Weakness: a Case Report of an Autosomal Recessive MFN2
Compound Heterozygote
-
Poster #383: Discovery and Clinical Interpretation of a SMAD4
Retrotransposon Using Next-Generation Sequencing
-
Poster #415: A Weighted, Score-Based Variant Classification System
Based on the 2014 Draft ACMG Guidelines
-
Poster #577: What Do We Do With VUS?: Genetics Professionals'
Attitudes Toward Reporting of Variants of Uncertain Significance
Poster Session 2: Friday, March 27, 10:30 a.m. – 12:00 p.m. MT
-
Poster #118: An Opportunity or a Dilemma? Customizable Panel Tests
and Clinician Ordering Behavior
For more detailed information, please visit http://www.acmgmeeting.net/acmg2015/public/mainhall.aspx
About Invitae
Invitae’s (NYSE: NVTA) mission is to bring comprehensive genetic
information into mainstream medical practice to improve the quality of
healthcare for billions of people. Currently focused on hereditary
cancers, Invitae’s goal is to aggregate most of the world’s genetic
tests into a single service with higher quality, faster turnaround time
and lower price than many single-gene tests today. The company currently
provides a single diagnostic test comprising over 200 genes for a
variety of genetic conditions associated primarily with cancer, but also
covering cardiology, hematology, neurology and pediatrics.
Source: Invitae Corporation